Frederic Bigot

Nantes, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Nantes, FR 

Overview

Frederic Bigot practices in Nantes, France. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Breast Cancer, and Lung Metastases.

His clinical research consists of co-authoring 28 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Nantes, 44805, France
Other Locations
Angers, France
France
Gustave Roussy
Villejuif, France
Cochin Port Royal Hospital, Sorbonne Paris Cité 123, Boulevard De Port Royal, Paris, 75014, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An International Multicentric Randomized Phase II Evaluating Dostarlimab in Combination With Niraparib Versus Niraparib Alone Compared to Chemotherapy in the Treatment of Metastatic or Recurrent Endometrial or Ovarian Carcinosarcoma After at Least One Line of Chemotherapy
An International Multicentric Randomized Phase II Evaluating Dostarlimab in Combination With Niraparib Versus Niraparib Alone Compared to Chemotherapy in the Treatment of Metastatic or Recurrent Endometrial or Ovarian Carcinosarcoma After at Least One Line of Chemotherapy
Enrollment Status: Recruiting
Publish Date: December 19, 2025
Intervention Type: Drug, Combination product
Study Drug: Niraparib
Study Phase: Phase 2/Phase 3
Prediction in Silico of Overall Survival in a Pilot Prospective Cohort Study of Metastatic Breast Cancer Patients
Prediction in Silico of Overall Survival in a Pilot Prospective Cohort Study of Metastatic Breast Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2025
Intervention Type: Biological, Procedure, Behavioral
Study Phase: Not Applicable
A National, Multicenter, Randomized Controlled Trial to Assess the Efficacy of a Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Women With Metastatic Breast Cancer
A National, Multicenter, Randomized Controlled Trial to Assess the Efficacy of a Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Women With Metastatic Breast Cancer
Enrollment Status: Unknown
Publish Date: August 21, 2024
Intervention Type: Device
Study Phase: Not Applicable
An International, Multi-Center, Open-Label, Randomized, Phase III Trial of Sacituzumab Govitecan Versus Treatment of Physician Choice in Patients With Metastatic Triple-Negative Breast Cancer Who Received at Least Two Prior Treatments
An International, Multi-Center, Open-Label, Randomized, Phase III Trial of Sacituzumab Govitecan Versus Treatment of Physician Choice in Patients With Metastatic Triple-Negative Breast Cancer Who Received at Least Two Prior Treatments
Enrollment Status: Completed
Publish Date: June 15, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

28 Total Publications

Blood Sample Preparation for Human Chemical Exposomics: Insights from Large-Scale Applications.
Blood Sample Preparation for Human Chemical Exposomics: Insights from Large-Scale Applications.
Journal: Environmental science & technology
Published: September 30, 2025

Frequently Asked Questions about Frederic Bigot

Is Frederic Bigot a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Frederic Bigot is classified as an Experienced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Frederic Bigot participate in research or clinical trials?

Yes. Frederic Bigot has published 28 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Frederic Bigot's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bigot's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile